圣湘生物等在湖南新设股权投资基金,出资额8.2亿

Core Insights - Hunan Jinfurong Shengxiang Biological Equity Investment Fund Partnership has been established with a total investment of 820 million yuan, focusing on private equity investment, investment management, and asset management activities [1][2]. Group 1: Company Overview - The fund is a limited partnership and is registered in Changsha, Hunan Province, with a business duration from February 9, 2026, to 2034 [2]. - The main operating location is at Jiangjiang Fund Town, Changsha, Hunan Province [2]. Group 2: Investment Structure - The fund's major partners include: - Shengxiang Biological Technology Co., Ltd. with a contribution ratio of 45.12% [3]. - Hunan Jinmeirong Industrial Guidance Fund Partnership with a contribution ratio of 26.83% [3]. - Hunan Xiangjiang New Area Guidance No. 4 Equity Investment Partnership with a contribution ratio of 18.29% [3]. - Changsha Technology Achievement Transformation Angel Investment Guidance Fund Partnership with a contribution ratio of 8.54% [3].

Sansure Biotech-圣湘生物等在湖南新设股权投资基金,出资额8.2亿 - Reportify